Central serous chorioretinopathy: a review of epidemiology and pathophysiology
暂无分享,去创建一个
Gerald Liew | G. Liew | M. Gillies | Samantha Fraser-Bell | S. Fraser-Bell | Godfrey Quin | Mark Gillies | G. Quin
[1] T. Rimmer,et al. Central serous chorioretinopathy following oral tadalafil , 2012, Eye.
[2] P. Edwards,et al. Central serous chorioretinopathy in African Americans. , 2003, Journal of the National Medical Association.
[3] A. Scialdone,et al. Eight-year follow-up of central serous chorioretinopathy with and without laser treatment , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.
[4] Timothy G Murray,et al. FACTORS ASSOCIATED WITH REDUCED VISUAL ACUITY DURING LONG-TERM FOLLOW-UP OF PATIENTS WITH IDIOPATHIC CENTRAL SEROUS CHORIORETINOPATHY , 2002, Retina.
[5] Wolfgang Drexler,et al. State-of-the-art retinal optical coherence tomography , 2008, Progress in Retinal and Eye Research.
[6] J. Melby,et al. Endocrine abnormalities in patients with central serous chorioretinopathy. , 2003, Ophthalmology.
[7] G. Virgili,et al. [ICG angiography and retinal pigment epithelial decompensation (CRSC and epitheliopathy)]. , 2001, Journal francais d'ophtalmologie.
[8] J. Slakter,et al. Central serous chorioretinopathy in younger and older adults. , 1996, Ophthalmology.
[9] A. Fawzi,et al. Central serous chorioretinopathy after solid organ transplantation. , 2006, Ophthalmology.
[10] Frederick W. Fraunfelder,et al. Central Serous Chorioretinopathy Associated With Sildenafil , 2008, Retina.
[11] M F Marmor,et al. The resorption of subretinal fluid after diffuse damage to the retinal pigment epithelium. , 1983, Investigative ophthalmology & visual science.
[12] K. Harada,et al. Six cases of central serous choroidopathy induced by systemic corticosteroid therapy , 1985, Documenta Ophthalmologica.
[13] A. Tsujikawa,et al. High-resolution imaging of resolved central serous chorioretinopathy using adaptive optics scanning laser ophthalmoscopy. , 2010, Ophthalmology.
[14] M. Spitznas. Pathogenesis of central serous retinopathy: A new working hypothesis , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.
[15] M. Shanmugam,et al. Visual outcome after discontinuation of corticosteroids in atypical severe central serous chorioretinopathy. , 2004, Ophthalmology.
[16] Judy E. Kim,et al. Photodynamic therapy for steroid-associated central serous chorioretinopathy , 2010, British Journal of Ophthalmology.
[17] D. Bujarborua. Long-term follow-up of idiopathic central serous chorioretinopathy without laser. , 2001, Acta ophthalmologica Scandinavica.
[18] C. Spahn,et al. Psychosomatic aspects in patients with central serous chorioretinopathy , 2003, The British journal of ophthalmology.
[19] R. Spaide,et al. Fundus autofluorescence and central serous chorioretinopathy. , 2005, Ophthalmology.
[20] Masanori Hangai,et al. Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy. , 2012, Ophthalmology.
[21] D. Robertson,et al. The long-term outcome of central serous chorioretinopathy. , 1996, Archives of ophthalmology.
[22] J D Gass,et al. Pathogenesis of disciform detachment of the neuroepithelium. , 1967, American journal of ophthalmology.
[23] C. S. Lee,et al. CENTRAL SEROUS CHORIORETINOPATHY AFTER RENAL TRANSPLANTATION , 2011, Retina.
[24] J. Gass,et al. Idiopathic central serous chorioretinopathy. , 1998, Indian journal of ophthalmology.
[25] A. Thoelen,et al. Obstructive sleep apnea in patients with central serous chorioretinopathy , 2008, Graefe's Archive for Clinical and Experimental Ophthalmology.
[26] C. Pournaras,et al. Central Serous Chorioretinopathy and Glucocorticoids , 2022 .
[27] M. Wakakura,et al. [Central serous chorioretinopathy induced by corticosteroids]. , 1997, Nippon Ganka Gakkai zasshi.
[28] R. Frank,et al. Central serous retinopathy and pregnancy. , 1974, American journal of ophthalmology.
[29] Frcs,et al. Central Serous Chorioretinopathy , 2012 .
[30] L. Yannuzzi,et al. Corticosteroids and central serous chorioretinopathy. , 2002, Ophthalmology.
[31] O. Chrapek,et al. [Treatment of central serous chorioretinopathy with beta blockers]. , 2002, Czech and Slovak Ophthalmology.
[32] F. Bandello,et al. Nonvisible Subthreshold Micropulse Diode Laser (810 nm) Treatment of Central Serous Chorioretinopathy: A Pilot Study , 2008, European journal of ophthalmology.
[33] J. Lim,et al. The Effect of Intravitreal Bevacizumab in Patients with Acute Central Serous Chorioretinopathy , 2010, Korean journal of ophthalmology : KJO.
[34] E. Neoh,et al. Graft-vs-host-disease-associated conjunctival chemosis and central serous chorioretinopathy after bone marrow transplant. , 2002, American journal of ophthalmology.
[35] R. Spaide,et al. ENHANCED DEPTH IMAGING OPTICAL COHERENCE TOMOGRAPHY OF THE CHOROID IN CENTRAL SEROUS CHORIORETINOPATHY , 2009, Retina.
[36] J. Pulido,et al. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002. , 2008, Ophthalmology.
[37] C. Shields. Autofluorescence from the outer retina and subretinal space: hypothesis and review , 2009 .
[38] Yasuo Tano,et al. Three-dimensional optical coherence tomographic findings in central serous chorioretinopathy , 2006, Graefe's Archive for Clinical and Experimental Ophthalmology.
[39] D. Ilstrup,et al. Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy. , 1983, American journal of ophthalmology.
[40] A. Fawzi,et al. Central serous chorioretinopathy after bone marrow transplantation. , 2001, American journal of ophthalmology.
[41] A. Koh,et al. Angiographic characteristics of acute central serous chorioretinopathy in an Asian population. , 2006, Annals of the Academy of Medicine, Singapore.
[42] E. Cunningham,et al. Central serous chorioretinopathy in patients with systemic lupus erythematosus. , 1996, Ophthalmology.
[43] G. Dutton,et al. Central Visual Function in Patients With Resolved Central Serous Retinopathy: A Long-Term Followup Study , 1990 .
[44] A. Bird,et al. Abnormalities of fundus autofluorescence in central serous retinopathy. , 2002, American journal of ophthalmology-glaucoma.
[45] A. Stigliano,et al. Central Serous Chorioretinopathy as a Presenting Symptom of Endogenous Cushing Syndrome: A Case Report , 2011, European journal of ophthalmology.
[46] M. Mäntyjärvi,et al. Contrast sensitivity in patients recovered from central serous chorioretinopathy , 2004, International Ophthalmology.
[47] M. Iovene,et al. Central Serous Chorioretinopathy and Helicobacter Pylori , 2006, European journal of ophthalmology.
[48] Guang-Hui Wang,et al. Value of Three-Dimensional Optical Coherence Tomography and Fundus Photochromy in Correlating the Fluorescein Leaking Sites of Acute Central Serous Chorioretinopathy , 2011, Medical Principles and Practice.
[49] M. Gao,et al. [Morphologic changes in acute central serous chorioretinopathy evaluated by spectral domain optical coherence tomography]. , 2011, [Zhonghua yan ke za zhi] Chinese journal of ophthalmology.
[50] L. Yannuzzi. TYPE-A BEHAVIOR AND CENTRAL SEROUS CHORIORETINOPATHY , 2012, Retina.
[51] S. W. Kang,et al. Choroidal thickness in both eyes of patients with unilaterally active central serous chorioretinopathy , 2011, Eye.
[52] R. Ebner,et al. True, true and related? , 2001, Survey of ophthalmology.
[53] M. Goff,et al. THE NATURAL HISTORY OF PIGMENT EPITHELIAL DETACHMENT ASSOCIATED WITH CENTRAL SEROUS CHORIORETINOPATHY , 2007, Retina.
[54] L. Schmetterer,et al. Choroidal hemodynamic changes during isometric exercise in patients with inactive central serous chorioretinopathy. , 2005, Investigative ophthalmology & visual science.
[55] K. Freund,et al. THE EFFECTS OF SILDENAFIL CITRATE ON CHOROIDAL THICKNESS AS DETERMINED BY ENHANCED DEPTH IMAGING OPTICAL COHERENCE TOMOGRAPHY , 2011, Retina.
[56] F. Boscia,et al. Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial. , 2010, American journal of ophthalmology.
[57] J. Lim,et al. The efficacy of intravitreal bevacizumab for idiopathic central serous chorioretinopathy , 2011, Graefe's Archive for Clinical and Experimental Ophthalmology.
[58] Ritu Gadia,et al. Sympathetic-parasympathetic activity and reactivity in central serous chorioretinopathy: a case-control study. , 2006, Investigative ophthalmology & visual science.
[59] R. Spaide. AUTOFLUORESCENCE FROM THE OUTER RETINA AND SUBRETINAL SPACE: Hypothesis and Review , 2008, Retina.
[60] F C Piccolino,et al. CENTRAL SEROUS CHORIORETINOPATHY AND INDOCYANINE GREEN ANGIOGRAPHY , 1994, Retina.
[61] P. Venkatesh,et al. Comparative evaluation of diode laser versus argon laser photocoagulation in patients with central serous retinopathy: A pilot, randomized controlled trial [ISRCTN84128484] , 2004, BMC ophthalmology.
[62] C. Giusti. Association of Helicobacter pylori with central serous chorioretinopathy: hypotheses regarding pathogenesis. , 2005, Medical hypotheses.
[63] C. Margo,et al. CENTRAL SEROUS CHORIORETINOPATHY AND PHOSPHODIESTERASE-5 INHIBITORS: A Case–Control Postmarketing Surveillance Study , 2010, Retina.
[64] C. Eandi,et al. Photodynamic Therapy for Chronic Central Serous Chorioretinopathy , 2003, Retina.
[65] J. Slakter,et al. INDOCYANINE GREEN ANGIOGRAPHY‐GUIDED PHOTODYNAMIC THERAPY FOR TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: A Pilot Study , 2003, Retina.
[66] Joo Yong Lee,et al. Intravitreal bevacizumab versus the conventional protocol of photodynamic therapy for treatment of chronic central serous chorioretinopathy , 2011, Acta ophthalmologica.
[67] E. Chew,et al. FINASTERIDE FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY , 2011, Retina.
[68] Miki Sawa,et al. Association between the efficacy of photodynamic therapy and indocyanine green angiography findings for central serous chorioretinopathy. , 2010, American journal of ophthalmology.
[69] J. Flammer,et al. The potential role of testosterone in central serous chorioretinopathy , 2006, British Journal of Ophthalmology.
[70] G. Ravera,et al. RISK FACTORS FOR POSTERIOR CYSTOID RETINAL DEGENERATION IN CENTRAL SEROUS CHORIORETINOPATHY , 2008, Retina.
[71] N. Eter,et al. Ketoconazole in the treatment of central serous chorioretinopathy: a pilot study , 2009, Acta ophthalmologica.
[72] A. Lotery,et al. Central serous chorioretinopathy: an update on pathogenesis and treatment , 2010, Eye.
[73] T. Lim,et al. Central serous retinopathy complicating systemic lupus erythematosus: a case series , 2000, Clinical & experimental ophthalmology.
[74] Sun Jinghua,et al. Effect of catecholamine on central serous chorioretinopathy , 2008, Journal of Huazhong University of Science and Technology [Medical Sciences].
[75] N. Kerr,et al. Phosphodiesterase inhibitors and the eye , 2009, Clinical & experimental ophthalmology.
[76] J. Ruiz-Moreno,et al. Photodynamic therapy for chronic central serous chorioretinopathy , 2009, Acta ophthalmologica.
[77] L. Yannuzzi,et al. Peripheral Retinal Detachments and Retinal Pigment Epithelial Atrophic Tracts Secondary to Central Serous Pigment Epitheliopathy , 2012, Ophthalmology.
[78] S. Fine,et al. Long-term follow-up of central serous chorioretinopathy. , 1984, The British journal of ophthalmology.
[79] A. Tatham,et al. The use of propranolol to treat central serous chorioretinopathy: an evaluation by serial OCT. , 2006, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[80] C. Schmid,et al. Central serous chorioretinopathy associated with a carcinoma of the adrenal cortex. , 2000, Retina.
[81] S. Fine,et al. Central serous chorioretinopathy and pregnancy. , 1993, Archives of ophthalmology.
[82] J. Castro-Correia,et al. Long-term follow-up of central serous retinopathy in 150 patients , 2004, Documenta Ophthalmologica.
[83] L. Jampol,et al. ORAL MIFEPRISTONE FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY , 2011, Retina.
[84] J. Slakter,et al. Systemic findings associated with central serous chorioretinopathy. , 1999, American journal of ophthalmology.
[85] M. Friedman,et al. Elevated Daytime Urinary Excretion of Testosterone Glucuronide in Men with the Type A Behavior Pattern , 1984, Psychosomatic medicine.
[86] D. Gagnon,et al. Risk factors for central serous chorioretinopathy: a case-control study. , 2004, Ophthalmology.
[87] S. Hayasaka,et al. Fluorescein-angiographic patterns in patients with central serous chorioretinopathy at the initial visit. , 1992, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.
[88] J. Jonas,et al. Intravitreal triamcinolone acetonide and central serous chorioretinopathy , 2005, British Journal of Ophthalmology.
[89] A. Javadzadeh,et al. The effect of Helicobacter pylori treatment on remission of idiopathic central serous chorioretinopathy , 2011, Molecular vision.
[90] J. Oosterhuis,et al. Familial Chronic Central Serous Chorioretinopathy , 2001, Ophthalmologica.
[91] T. Lai,et al. Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial. , 2008, Ophthalmology.
[92] J. Gass. Central serous chorioretinopathy and white subretinal exudation during pregnancy. , 1991, Archives of ophthalmology.
[93] H. Bahçecioğlu,et al. Intravitreal Bevacizumab in Treatment of Idiopathic Persistent Central Serous Chorioretinopathy: A Prospective, Controlled Clinical Study , 2010, Current eye research.
[94] San-Ni Chen,et al. Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage. , 2008, Ophthalmology.
[95] L. Laatikainen,et al. Long-term follow-up Study of Nonsenile Detachment of the Retinal Pigment Epithelium , 1991, European journal of ophthalmology.
[96] S. Harino,et al. Two cases of central serous chorioretinopathy treated with photocoagulation after bone marrow transplantation. , 2002, Retina.
[97] D. Talwar,et al. Endogenous cortisol profile in patients with central serous chorioretinopathy , 1997, The British journal of ophthalmology.
[98] D. Boyer,et al. Chronic central serous chorioretinopathy: photodynamic therapy. , 2004, American journal of ophthalmology.
[99] K. Imbierowicz,et al. [Central serous chorioretinopathy and psychological stress]. , 2000, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.
[100] S. Kang,et al. Comparative study of patients with central serous chorioretinopathy undergoing focal laser photocoagulation or photodynamic therapy , 2010, British Journal of Ophthalmology.
[101] R B Rosen,et al. Evaluation of central serous retinopathy with en face optical coherence tomography , 2005, British Journal of Ophthalmology.
[102] G. Ravera,et al. The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. , 2005, American journal of ophthalmology.
[103] Atul K. Jain,et al. Bilateral central serous chorioretinopathy resolving rapidly with treatment for obstructive sleep apnea , 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.
[104] F. Geiser,et al. Chorioretinopathia centralis serosa und psychische Belastung , 2000, Der Ophthalmologe.
[105] J. Flammer,et al. Choroidal capillary and venous congestion in central serous chorioretinopathy. , 1996, American journal of ophthalmology.
[106] L. Ficker,et al. Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy. , 1988, The British journal of ophthalmology.
[107] J. Fabianová,et al. [Central serous chorioretinopathy--treatment with beta blockers]. , 1998, Czech and Slovak Ophthalmology.
[108] Richard Hackel,et al. DETECTION OF RETINAL METABOLIC STRESS RESULTING FROM CENTRAL SEROUS RETINOPATHY , 2009, Retina.
[109] Michael D. Ober,et al. ACUTE CENTRAL SEROUS CHORIORETINOPATHY AND FUNDUS AUTOFLUORESCENCE , 2005, Retina.
[110] Soon-Sun Kwon,et al. COMPARISON OF CHOROIDAL THICKNESS AMONG PATIENTS WITH HEALTHY EYES, EARLY AGE-RELATED MACULOPATHY, NEOVASCULAR AGE-RELATED MACULAR DEGENERATION, CENTRAL SEROUS CHORIORETINOPATHY, AND POLYPOIDAL CHOROIDAL VASCULOPATHY , 2011, Retina.
[111] A. Safran,et al. Should Central Serous Chorioretinopathy Be Added to the List of Ocular Side Effects of Phosphodiesterase 5 Inhibitors? , 2011, Ophthalmologica.
[112] G. Gelber,et al. Loss of vision due to central serous chorioretinopathy following psychological stress. , 1987, The American journal of psychiatry.
[113] A. Ho,et al. Digital indocyanine green videoangiography of central serous chorioretinopathy. , 1994, Archives of ophthalmology.
[114] M. Kaiser-Kupfer,et al. Central serous chorioretinopathy in endogenous hypercortisolism. , 1993, Archives of ophthalmology.
[115] Kazuhiko Hayashi,et al. Indocyanine green angiography of central serous chorioretinopathy , 1986, International Ophthalmology.
[116] D. Park,et al. Central Serous Chorioretinopathy in Two Families , 1998, European journal of ophthalmology.
[117] Y. Tano,et al. Morphologic changes in acute central serous chorioretinopathy evaluated by fourier-domain optical coherence tomography. , 2008, Ophthalmology.
[118] R. Chervin,et al. Central serous chorioretinopathy and risk for obstructive sleep apnea , 2007, Sleep and Breathing.
[119] J. Gomolin. Choroidal neovascularization and central serous chorioretinopathy. , 1989, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[120] T. Gardner,et al. Central serous chorioretinopathy in women. , 1996, Ophthalmology.
[121] C. Spahn,et al. [Operationalized psychodynamic diagnostics (OPD) in patients with central serous chorioretinopathy]. , 2004, PPmP. Psychotherapie, Psychosomatik, medizinische Psychologie.
[122] P Leaver,et al. Argon laser photocoagulation in the treatment of central serous retinopathy. , 1979, The British journal of ophthalmology.
[123] N. Evans,et al. Central serous chorioretinopathy associated with testosterone therapy , 2006, Eye.
[124] I. Toda,et al. Identification of androgen receptor protein and 5α-reductase mRNA in human ocular tissues , 2000, The British journal of ophthalmology.
[125] E Niskanen,et al. MARROW TRANSPLANTATION , 1977, Duodecim; laaketieteellinen aikakauskirja.
[126] G. Holder,et al. Visual loss from central serous retinopathy in systemic lupus erythematosus. , 1993, The British journal of ophthalmology.
[127] O. Sharma,et al. Sarcoidosis and central serous retinopathy: a dangerous combination. , 1998, Sarcoidosis Vasculities and Diffuse Lung Diseases.
[128] James G. Fujimoto,et al. CHOROIDAL IMAGING USING SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY , 2012, Retina.
[129] J. Lim,et al. AQUEOUS HUMOR AND PLASMA LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND INTERLEUKIN-8 IN PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY , 2010, Retina.
[130] F. Piccolino,et al. Posterior Cystoid Retinal Degeneration in Central Serous Chorioretinopathy , 2008, Retina.